Clinical Trial: A Study of HRS-9057 in Patients With Heart Failure and Volume Overload
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Heart Failure With Volume Overload
Study Type: INTERVENTIONAL
Official Title: An Open Label, Tolvaptan-controlled Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Multiple Ascending Dose of HRS-9057 in Heart Failure With Vo
Brief Summary:
The study is an open-label, Tolvaptan-controlled Phase I study to evaluate the safety, tolerability, PK/PD profile and efficacy of HRS-9057 in the treatment of heart failure with volume overload.A total of 24 subjects who experience volume overload due to heart failure despite diuretic treatment will be enrolled in the study and receive HRS-9057 injection or Tolvaptan tablets.
Read more